Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of S(+)-Ketamine for Postoperative Acute Pain
NCT04837170Phase 4Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- May 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of esketamine in postoperative pain, sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04837170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04837170.